Truist Financial Boosts Integral Ad Science (NASDAQ:IAS) Price Target to $17.00

Integral Ad Science (NASDAQ:IAS) had its target price lifted by analysts at Truist Financial from $16.00 to $17.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Truist Financial’s price target points to a potential upside of 62.84% from the stock’s current price.

IAS has been the subject of a number of other research reports. Benchmark reiterated a “hold” rating on shares of Integral Ad Science in a report on Friday. Oppenheimer reissued an “outperform” rating on shares of Integral Ad Science in a research report on Friday. Scotiabank began coverage on shares of Integral Ad Science in a report on Friday. They set a “sector perform” rating and a $12.00 target price on the stock. Barclays reissued an “equal weight” rating on shares of Integral Ad Science in a research report on Friday. Finally, Craig Hallum dropped their price objective on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Four research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $15.06.

Integral Ad Science Stock Performance

Integral Ad Science stock opened at $10.44 on Monday. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71. The firm has a market capitalization of $1.70 billion, a P/E ratio of 52.20, a price-to-earnings-growth ratio of 1.06 and a beta of 1.46. Integral Ad Science has a 1-year low of $7.98 and a 1-year high of $13.62. The company’s 50-day moving average is $10.34 and its 200 day moving average is $10.81.

Integral Ad Science (NASDAQ:IAS) last issued its quarterly earnings results on Friday, February 28th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.03). Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The business had revenue of $153.00 million during the quarter, compared to analysts’ expectations of $148.83 million. During the same quarter in the previous year, the company posted $0.06 earnings per share. The company’s quarterly revenue was up 13.9% compared to the same quarter last year. Research analysts forecast that Integral Ad Science will post 0.26 EPS for the current year.

Insider Activity at Integral Ad Science

In other Integral Ad Science news, CEO Lisa Utzschneider sold 12,448 shares of the firm’s stock in a transaction dated Tuesday, February 4th. The stock was sold at an average price of $10.61, for a total value of $132,073.28. Following the completion of the sale, the chief executive officer now owns 278,650 shares of the company’s stock, valued at approximately $2,956,476.50. This trade represents a 4.28 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold 19,109 shares of company stock valued at $197,696 over the last 90 days. Insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Integral Ad Science

Institutional investors and hedge funds have recently made changes to their positions in the stock. US Bancorp DE lifted its position in Integral Ad Science by 540.9% during the third quarter. US Bancorp DE now owns 35,776 shares of the company’s stock valued at $387,000 after purchasing an additional 30,194 shares during the period. Stoneridge Investment Partners LLC purchased a new stake in shares of Integral Ad Science in the third quarter worth about $125,000. TimesSquare Capital Management LLC grew its holdings in Integral Ad Science by 0.6% during the third quarter. TimesSquare Capital Management LLC now owns 2,772,440 shares of the company’s stock worth $29,970,000 after acquiring an additional 17,166 shares during the period. Oppenheimer & Co. Inc. acquired a new stake in Integral Ad Science during the third quarter worth about $281,000. Finally, Quest Partners LLC raised its position in Integral Ad Science by 101,255.9% during the third quarter. Quest Partners LLC now owns 34,461 shares of the company’s stock valued at $373,000 after acquiring an additional 34,427 shares in the last quarter. 95.78% of the stock is currently owned by institutional investors and hedge funds.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.